User profiles for Harry L.A. Janssen
Harry LA JanssenProfessor of Medicine, Erasmus MC, Rotterdam, Netherlands Verified email at erasmusmc.nl Cited by 68831 |
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
…, K Agarwal, T Berg, M Buti, HLA Janssen… - Journal of …, 2017 - Elsevier
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This Clinical …
epidemiology due to several factors including vaccination policies and migration. This Clinical …
[HTML][HTML] Treatment of HCV infection by targeting microRNA
HLA Janssen, HW Reesink, EJ Lawitz… - … England Journal of …, 2013 - Mass Medical Soc
Background The stability and propagation of hepatitis C virus (HCV) is dependent on a
functional interaction between the HCV genome and liver-expressed microRNA-122 (miR-122). …
functional interaction between the HCV genome and liver-expressed microRNA-122 (miR-122). …
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
… lecture activities or patents from Merck, Janssen, Roche, Gilead, and Medtronic, and research
grants from Merck and Roche. Dr Janssen reported receiving financial compensation for …
grants from Merck and Roche. Dr Janssen reported receiving financial compensation for …
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem… - The Lancet, 2005 - thelancet.com
Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in
most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral …
most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral …
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
…, BE Hansen, SW Schalm, HLA Janssen - Annals of internal …, 2007 - acpjournals.org
Background: Clinical outcomes of chronic hepatitis C infection in patients with advanced
fibrosis include liver failure, hepatocellular carcinoma, and death. Objective: To investigate …
fibrosis include liver failure, hepatocellular carcinoma, and death. Objective: To investigate …
[PDF][PDF] Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
…, EJ Kuipers, JG Kusters, HLA Janssen - …, 2005 - Wiley Online Library
Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to
HBV. Regulatory T cells (T reg ) can suppress the function of effector T cells and may thus be …
HBV. Regulatory T cells (T reg ) can suppress the function of effector T cells and may thus be …
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
Background & Aims Risk scores for hepatocellular carcinoma (HCC) developed in Asians
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
[PDF][PDF] Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
T Lisman, TN Bongers, J Adelmeijer, HLA Janssen… - …, 2006 - Wiley Online Library
Cirrhosis of the liver is frequently accompanied by complex alterations in the hemostatic
system, resulting in a bleeding tendency. Although many hemostatic changes in liver disease …
system, resulting in a bleeding tendency. Although many hemostatic changes in liver disease …
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow‐up study
…, M Primignani, JC Garcia‐Pagan, HLA Janssen… - …, 2010 - Wiley Online Library
Current recommendations for early anticoagulation in acute portal vein thrombosis unrelated
to cirrhosis or malignancy are based on limited evidence. The aim of this study was to …
to cirrhosis or malignancy are based on limited evidence. The aim of this study was to …
Hepatitis B virus infection
…, DS Chen, GM Dusheiko, HLA Janssen… - Nature reviews Disease …, 2018 - nature.com
Hepatitis B virus (HBV) is a hepatotropic virus that can establish a persistent and chronic
infection in humans through immune anergy. Currently, 3.5% of the global population is …
infection in humans through immune anergy. Currently, 3.5% of the global population is …